Ticker ACET – Adicet Bio – sales, description, marketcap – Tickerday.com

ACET

Adicet Bio

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 456.77M; Volume: 156.11K; AvgVol 3m: 162.30K; Beta: –;

Cost estimate:

P/E: –; EPS: -1.97; EPS growth quarter/prev quarter: 70.10%;

EPS growth this year: -69.50%; EPS growth past 5 years: ;

EPS ttm: -13.79;

P/S: 55.87; P/B: 0.89; P/Cashflow: 3.46; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: 125.90%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -71.60%; ROE – return on equity: -78.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: ; Insider Transactions:;

Institutional Ownership: 12.40%; Institutional Transactions: 25.96%;

Data update: 07.10.2020.